(Q46463069)

22 December 2017

title

Malondialdehyde, carbonyl proteins and albumin-disulphide as useful oxidative markers in mild cognitive impairment and Alzheimer's disease (English)

1 reference

22 December 2017

mild cognitive impairment

main subject

Alzheimer's disease

0 references

1 reference

based on heuristic

inferred from title

cognitive dysfunction

1 reference

J Greilberger

1

1 reference

22 December 2017

C Koidl

2

1 reference

22 December 2017

M Greilberger

3

1 reference

22 December 2017

M Lamprecht

4

1 reference

22 December 2017

K Schroecksnadel

5

1 reference

22 December 2017

F Leblhuber

6

1 reference

22 December 2017

D Fuchs

7

1 reference

22 December 2017

K Oettl

8

1 reference

22 December 2017

publication date

1 July 2008

1 reference

22 December 2017

published in

Free Radical Research

1 reference

22 December 2017

volume

42

1 reference

22 December 2017

issue

7

1 reference

22 December 2017

page(s)

633-638

1 reference

22 December 2017

Oxidative stress and reduced antioxidant defenses in peripheral cells from familial Alzheimer's patients

cites work

1 reference

https://api.crossref.org/works/10.1080%2F10715760802255764

Is oxidative damage the fundamental pathogenic mechanism of Alzheimer's and other neurodegenerative diseases?

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F10715760802255764

Oxidative damage in Alzheimer's.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F10715760802255764

Proteomic identification of proteins oxidized by Abeta(1-42) in synaptosomes: implications for Alzheimer's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F10715760802255764

Hydroxynonenal, toxic carbonyls, and Alzheimer disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F10715760802255764

Carbonyl toxicology and Alzheimer's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F10715760802255764

Increase of brain oxidative stress in mild cognitive impairment: a possible predictor of Alzheimer disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F10715760802255764

Protein oxidation in aging brain

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F10715760802255764

Evidence of increased oxidative damage in subjects with mild cognitive impairment.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F10715760802255764

Chemistry and biochemistry of oxidative stress in neurodegenerative disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F10715760802255764

Involvement of free radicals in dementia of the Alzheimer type: a hypothesis

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F10715760802255764

Interplay between oxidative damage, protein synthesis, and protein degradation in Alzheimer's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F10715760802255764

Oxidative inactivation of the proteasome in Alzheimer's disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F10715760802255764

Oxidatively modified RNA in mild cognitive impairment

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F10715760802255764

Decreased RNA, and increased RNA oxidation, in ribosomes from early Alzheimer's disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F10715760802255764

Evidence of oxidative damage in Alzheimer's disease brain: central role for amyloid beta-peptide

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F10715760802255764

Identification of oxidized plasma proteins in Alzheimer's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F10715760802255764

Oxidatively modified proteins in aging and disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F10715760802255764

Chemistry and biochemistry of 4-hydroxynonenal, malonaldehyde and related aldehydes

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F10715760802255764

Elevated thiobarbituric acid-reactive substances and antioxidant enzyme activity in the brain in Alzheimer's disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F10715760802255764

Albumin-bound polyacrolein: implications for Alzheimer's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F10715760802255764

Albumin is the major plasma protein target of oxidant stress in uremia

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F10715760802255764

Oxidative stress and nitration in neurodegeneration: cause, effect, or association?

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F10715760802255764

Clinical diagnosis of Alzheimer's disease: report of the NINCDS-ADRDA Work Group under the auspices of Department of Health and Human Services Task Force on Alzheimer's Disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F10715760802255764

Mild cognitive impairment: clinical characterization and outcome

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F10715760802255764

Rapid measurement of total plasma homocysteine by HPLC

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F10715760802255764

Analytical aspects of oxidatively modified substances in sports and exercises

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F10715760802255764

Evaluation of serum-lipid-related cardiovascular risk factors in Alzheimer's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F10715760802255764

Iron accumulation in Alzheimer disease is a source of redox-generated free radicals

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F10715760802255764

Peripheral levels of glutathione and protein oxidation as markers in the development of Alzheimer's disease from Mild Cognitive Impairment

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F10715760802255764

Increased oxidized form of human serum albumin in patients with diabetes mellitus

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F10715760802255764

Identification of cognitive impairment in the elderly: homocysteine is an early marker.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F10715760802255764

Total serum homocysteine in senile dementia of Alzheimer type

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F10715760802255764

Homocysteine versus the vitamins folate, B6, and B12 as predictors of cognitive function and decline in older high-functioning adults: MacArthur Studies of Successful Aging

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F10715760802255764

Total homocysteine and cognitive decline in a community-based sample of elderly subjects: the Rotterdam Study.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F10715760802255764

Elevated plasma homocysteine levels in centenarians are not associated with cognitive impairment.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F10715760802255764

Plasma homocysteine, vitamin B12 and folate in Alzheimer's patients and healthy Arabs in Israel

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F10715760802255764

Increased oxidative stress in Alzheimer's disease as assessed with 4-hydroxynonenal but not malondialdehyde

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F10715760802255764

10.1080/10715760802255764

21 January 2018

Identifiers

DOI

1 reference

22 December 2017

PubMed ID

18654878

1 reference

22 December 2017